St Helens Place - On Demand Availability of Intravenous Antibiotics (Pharmacy)
A Contract Award Notice
by NHS CHESHIRE AND MERSEYSIDE INTEGRATED CARE BOARD
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £2K
- Sector
- HEALTH
- Published
- 01 May 2025
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
East Merseyside:
1 buyer
1 supplier
- Aim RX St Helens
Description
Participating pharmacies will provide an Intravenous Antibiotic stockholding service for the patients in St Helens. The aim of the service is to improve the care of patients who require intravenous therapy in the community by ensuring pharmacies have sufficient stock of appropriate IV antibiotics during core hours
Total Quantity or Scope
NHS Cheshire and Merseyside ICB has awarded a one year contract via Direct Award A to selected St Helens pharmacies across Cheshire and Merseyside. The contract commenced on 1st April 2024 and expired on the 31st March 2025. The contract value is estimated to be £1680.00. This contract is activity based and can vary on an annual basis. Funding is based on delivery of the activity as outlined within the service specification.
Award Detail
| 1 | Aim RX (St Helens)
|
Award Criteria
| Patient Choice | 99 |
| price | 1 |
CPV Codes
- 85100000 - Health services
Legal Justification
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. On the 12th of March 2024 the Finance, Investment, Resources Committee approved this decision. Two committee members had a standing declaration of interest. The decision to award was made in line with the Conflict of Interest policy.
Reference
- ocds-h6vhtk-050ba0
- FTS 018518-2025